Hull et al. (2022) conducted a large, prospective, open-label effectiveness trial which found that at-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (4)

• ketamine concept
• depression concept
• anxiety concept
• telehealth concept